TruDoc Raises $15 Million to Speed Up Virtual Healthcare in the GCC
TruDoc, a leading virtual-first healthcare provider in the Gulf region, has successfully raised $15 million in pre-Series B funding. This major investment aims to accelerate the company’s mission to revolutionize digital health access and reshape the way patients connect with healthcare services across the Gulf Cooperation Council (GCC).
The round was jointly led by Dubai-based venture capital firm B&Y Venture Partners and PIF-backed Jahez Group, demonstrating strong regional investor confidence in TruDoc’s goals. The company plans to use the funds to strengthen its digital health platform, expand its service offerings, and scale up operations across the GCC, including Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman, and Bahrain.
The fresh injection of capital is also set to enhance AI-powered healthcare solutions, making healthcare more efficient, personalized, and accessible for millions of patients in the region. This move aligns with broader government initiatives to prioritize digital transformation in healthcare and improve overall patient experience.
According to the company, the funding will allow them to expand their telehealth services, invest in next-generation technologies, and develop strategic partnerships with regional healthcare providers. This is expected to address the growing demand for quality healthcare solutions and to streamline patient-doctor interactions through digital platforms.
Ahmed Sharif, CEO of TruDoc, expressed optimism about the future of digital healthcare in the region. He stated, “This new investment will empower TruDoc to further advance our mission of providing seamless, virtual-first care to millions. Our enhanced digital platform will transform the healthcare experience and support the GCC’s bold vision for the future of health.”
With the successful funding round, TruDoc is poised to play a leading role in shaping the future of virtual-first healthcare across the GCC, aiming to set new benchmarks in convenience, quality, and patient outcomes.
Team V.INO-LNK
